If you google ‘open label extension’, the first dozen articles mention the unethical nature of them, including a few articles from the NIH.

Some how they got on Fox News a few times and positive articles in WSJ.com. All we get are hit pieces any time we’re mentioned by MSM. Frustrating.

Hahaha love it! Do you like your oatmeal lumpy too??

Dang this board got a little busy again. I try to check in every couple weeks or so. Good to see some of the old timers still here and some new faces too! Glta

EUA coming earlier methinks.

You have a dizzying intellect. Good night.

Lemme guess, if I check your post history I bet I’ll find that this is your first ever post here, and you have 10,000 posts on the cyfy board.

Cool take. It’s funny how we all see things differently.

Yeah I have it on in the background and my ears perked up as they started taking therapeutics. 90% of the talk has been about vaccines so far.

He didn’t mention Lenz. I just don’t get it.

He mentioned “gmcsf” and “cytokine storm” and mentioned other big boy company names and their lousy drugs by name. But not Lenz.

No promotion, no following. Kind of reminds me of FATE. Hardly anyone talked about them when I bought in the low teens last year and now it’s at $90.

Wait what? They raised 500m? Didn’t even think they were a real company or competition.

I thought so too. Surprised no one seems excited about this. It’s probably because a lot have given up waiting as I almost am.

Thanks, that wasn’t it. But jts surprising that one other person even mentioned it.

I remember someone mentioning that the doctor from Mayo who spoke about lenz will be presenting MABs to White House staff including Dr Birx this Thursday. Did anyone see this? I can’t remember where I saw it.

Was anyone else under the impression that data would be presented at ash today? Lately my attention has been elsewhere, guess I need to get back up to speed on things.

This is the stuff I’ve been waiting for!

3 conferences this week and hasn’t done shit for the share price. Not one new buyer??

Of course today’s mrna news will affect us. Any excuse to tank this stock will of course be capitalized on!

Lol I wish it were that simple doc. I lost track of all the halted trials and poor results coming from all these big names, and yet they mention all their names constantly.

I caught that too! He also said later “remember that number 85%”.

I’m truly puzzled as to why NIH, Mayo, Trump etc will not mention us in any meaningful way that would actually bring the attention of millions our way. Nothing makes sense to me unless this is all a scam and the drug is garbage, which I highly doubt. No explanation for this makes sense! Anyone have any scenario that I maybe have not thought of yet??

They’re almost too too obvious aren’t they knuckles??

Thanks for posting Pit, you’re being way too nice. Purposefully skewed interpretation and doesn’t even mention barda. Complete hit piece.
And this folks, is why this stock never goes anywhere.

Wow can anyone view the business insider article on hgen? Title sounds like another hit piece. Just retweeted to millions. That sucks.

It’s a bot. Not sure how this works. Maybe if enough of us contact support they will remove it?

Nice! Was wondering when we’d hear someone comment on this!

Gillead favoring Lenz over Mav for CAR T.

$KNSA down 6%. Perhaps partly related to $GILD seemingly prioritizing $HGEN GM-CSF over Mav for its CAR-T trial in DLBCL pic.twitter.com/oV1xFdYf4D

— M (@bio_clouseau) October 29, 2020

Why won’t nih tweet our name?? They have no problem saying Remdesivir. Jerks. “The trial, which will investigate the use of two different monoclonal antibodies in conjunction with remdesivir”

I was just about to say that jdc. Why PR this one hospital, which by the way is the largest in the DC area I believe.

I swear they are leaving us little breadcrumbs. They can’t come out and say it but they are slowly giving us the clues!

Disagree. It’s to make money for him and his friends.

It was so obvious from his talk today. He didn’t even know the drugs name but he made sure to say the name regeneron 17 times while talking about it. So obvious

Lol E*TRADE tells me 14.23

Tom you’re a hard dude to read. Sometimes you post some interesting stuff then all of a sudden you post crazy sht. Lol

It’s been 2 months since the company announced. Just feels strange.

I appreciate your enthusiasm guys. Based on the rate the gubment has moved us along, I doubt anything will happen soon. Where the f is the nih announcement??

Tell em Luda!

I’m referring to this:

“After 13 weeks, and following the U.S. Food and Drug Administration's issuance of an emergency use authorization, the patient was treated with lenzilumab”

https://www.fool.com/investing/2020/10/05/why-humanigen-stock-is-soaring-today

Did I miss something? Motley Fool article said the patient recently received Lenz via EUA?

I agree! Attitude has changed drastically this past week!

Imagine if on top of this pop the nih decides to drop their announcement as well. Could be setting up for a nice week.